Rising Healthcare Expenditure Fuels Growth In Enzyme Replacement Therapy (ERT) Market Is Supporting Development Across The Enzyme Replacement Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Is The Enzyme Replacement Therapy Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The enzyme replacement therapy market has experienced substantial expansion in recent years. This market is expected to increase from $12.36 billion in 2025 to $13.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The historical growth of this market can be attributed to factors such as the rising incidence of lysosomal storage disorders, progress in recombinant DNA technology, greater public awareness of rare diseases, enhanced hospital infrastructure, and governmental support for rare disease treatments.

The enzyme replacement therapy market is anticipated to experience substantial growth in the upcoming years. It is forecast to grow to $19.29 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This projected expansion is attributable to factors like the broadening scope of precision medicine, advancements in novel enzyme formulations, increasing adoption of home infusion therapies, the integration of digital health solutions, and a rise in collaborations between biotech companies and research institutes. Furthermore, major trends for the forecast period encompass personalized enzyme replacement therapies, an expansion of rare disease treatment programs, the development of long-acting enzyme formulations, the adoption of minimally invasive administration routes, and the incorporation of real-world evidence to optimize therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10512&type=smp

What Major Growth Factors Are Impacting The Enzyme Replacement Therapy Market?

The increase in healthcare spending is projected to stimulate the future growth of the enzyme replacement therapy (ERT) market. Healthcare expenditure refers to the total financial outlay on healthcare services, related goods, and activities within a specific healthcare system or economy over a defined period. This expenditure is critical for enzyme replacement therapy (ERT) primarily due to the specialized and often costly nature of these treatments, which require substantial investment in research and development, along with clinical trials and testing. For instance, according to the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, National Health Expenditure (NHE) rose by 7.5% to $4.9 trillion in 2023, or $14,570 per person, and constituted 17.6% of Gross Domestic Product (GDP) in June 2025. Hospital expenditures saw a 10.4% increase to $1,519.7 billion in 2023, a faster rate than the 3.2% growth recorded in 2022. Hence, the escalating healthcare expenditures are propelling the growth of the enzyme replacement therapy (ERT) market.

Which Segment Divisions Form The Structure Of The Enzyme Replacement Therapy Market?

The enzyme replacement therapy market covered in this report is segmented –

1) By Enzyme Type: Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types

2) By Route Of Administration: Oral, Parenteral

3) By Application: Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications

4) By End-Users: Hospitals, Infusion Centers, Other End-Users

What Trends Are Influencing The Enzyme Replacement Therapy Market?

Leading companies active in the enzyme replacement therapy (ERT) market are directing their efforts towards innovative treatment products and obtaining approvals for Pompe disease therapies to satisfy the unaddressed medical requirements of patients with late-onset Pompe disease. In the European Union, the treatment for Pompe disease, an enzyme replacement therapy for adults with late-onset Pompe disease, is comprised of Pombiliti (cipaglucosidase alfa) and Opfolda (miglustat). For example, in June 2023, Amicus Therapeutics, a US-based biotechnology company, announced the approval and introduction of a new Pompe disease therapy in the European Union. This action was taken to address the unmet medical need for patients with late-onset Pompe disease, bolstered by clinical data, driven by potential market opportunities, and supported by regulatory frameworks. This particular treatment, consisting of Pombiliti (cipaglucosidase alfa) and Opfolda (miglustat), functions as an enzyme replacement therapy for adults diagnosed with late-onset Pompe disease.

Who Are The Prominent Players Across The Enzyme Replacement Therapy Market?

Major companies operating in the enzyme replacement therapy market are Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Alexion Pharmaceuticals Inc., Recordati Rare Diseases Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc.

Access The Complete Enzyme Replacement Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

Which Region Commands The Largest Share Of The Enzyme Replacement Therapy Market?

North America was the largest region in the enzyme replacement therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Enzyme Replacement Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=10512&type=smp

Browse Through More Reports Similar to the Global Enzyme Replacement Therapy Market 2026, By The Business Research Company

Enzyme Replacement Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

Enzyme Inhibitor Market Report 2026

https://www.thebusinessresearchcompany.com/report/enzyme-inhibitor-global-market-report

Enzyme Market Report 2026

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795